Jazz’s ;The U.S. Food and Drug Administration has approved Jazz Pharmaceuticals’ Ziihera (zanidatamab-hrii) for previously untreated adults with unresectable,...
Executive Summary
Artificial intelligence is moving from a technology employees use to a capability that works alongside them.
Pharmaceutical companies have...
Executive Summary
Drug development is becoming increasingly data-driven, computational, and personalized. Yet pharmaceutical companies still rely heavily on physical experiments...
Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed for healthcare organizations. The tool...
Pharma Company:Executive Summary
Pharmaceutical companies have never had more data.
Research organizations generate molecular and genomic information. Clinical teams produce trial...
Executive Summary
Pharmaceutical customer engagement is undergoing a fundamental shift.
Healthcare professionals (HCPs) are exposed to growing volumes of scientific information,...